1-160115869-G-A

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2

The NM_000702.4(ATP1A2):​c.8G>A​(p.Arg3His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,601,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R3C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

ATP1A2
NM_000702.4 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 2.41
Variant links:
Genes affected
ATP1A2 (HGNC:800): (ATPase Na+/K+ transporting subunit alpha 2) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ATP1A2. . Gene score misZ 4.7713 (greater than the threshold 3.09). Trascript score misZ 6.824 (greater than threshold 3.09). GenCC has associacion of gene with fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, alternating hemiplegia of childhood, hemiplegic migraine-developmental and epileptic encephalopathy spectrum, familial or sporadic hemiplegic migraine, alternating hemiplegia of childhood 1, developmental and epileptic encephalopathy 98, migraine, familial hemiplegic, 2.
BP4
Computational evidence support a benign effect (MetaRNN=0.10315934).
BP6
Variant 1-160115869-G-A is Benign according to our data. Variant chr1-160115869-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 204902.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=3}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.000108 (157/1448958) while in subpopulation NFE AF= 0.000135 (149/1106218). AF 95% confidence interval is 0.000117. There are 0 homozygotes in gnomad4_exome. There are 68 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 16 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATP1A2NM_000702.4 linkuse as main transcriptc.8G>A p.Arg3His missense_variant 1/23 ENST00000361216.8 NP_000693.1 P50993A0A0S2Z3W6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATP1A2ENST00000361216.8 linkuse as main transcriptc.8G>A p.Arg3His missense_variant 1/231 NM_000702.4 ENSP00000354490.3 P50993
ATP1A2ENST00000392233.7 linkuse as main transcriptc.8G>A p.Arg3His missense_variant 1/235 ENSP00000376066.3 B1AKY9
ATP1A2ENST00000472488.5 linkuse as main transcriptn.111G>A non_coding_transcript_exon_variant 1/202
ATP1A2ENST00000478587.1 linkuse as main transcriptn.107G>A non_coding_transcript_exon_variant 1/23

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152154
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000483
AC:
11
AN:
227940
Hom.:
0
AF XY:
0.0000654
AC XY:
8
AN XY:
122376
show subpopulations
Gnomad AFR exome
AF:
0.0000705
Gnomad AMR exome
AF:
0.0000935
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000583
Gnomad SAS exome
AF:
0.0000366
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000487
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000108
AC:
157
AN:
1448958
Hom.:
0
Cov.:
31
AF XY:
0.0000946
AC XY:
68
AN XY:
719128
show subpopulations
Gnomad4 AFR exome
AF:
0.0000300
Gnomad4 AMR exome
AF:
0.0000468
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000480
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000135
Gnomad4 OTH exome
AF:
0.0000167
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152272
Hom.:
0
Cov.:
32
AF XY:
0.000107
AC XY:
8
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000115
Hom.:
0
Bravo
AF:
0.000155
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 14, 2024Variant summary: ATP1A2 c.8G>A (p.Arg3His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 227940 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ATP1A2 causing Alternating Hemiplegia Of Childhood 1, allowing no conclusion about variant significance. c.8G>A has been reported in the literature in at-least one individual affected with epilepsy (Coll_2017). These report(s) do not provide unequivocal conclusions about association of the variant with Alternating Hemiplegia Of Childhood 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 29261713). ClinVar contains an entry for this variant (Variation ID: 204902). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJan 12, 2015- -
Migraine, familial hemiplegic, 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterJul 06, 2020- -
Familial hemiplegic migraine Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 10, 2024This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 3 of the ATP1A2 protein (p.Arg3His). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ATP1A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 204902). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATP1A2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 08, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
25
DANN
Benign
0.92
DEOGEN2
Benign
0.21
T;.
Eigen
Benign
-0.032
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.74
T;T
M_CAP
Benign
0.078
D
MetaRNN
Benign
0.10
T;T
MetaSVM
Benign
-0.68
T
MutationAssessor
Benign
0.90
L;.
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-0.45
N;N
REVEL
Uncertain
0.43
Sift
Benign
0.53
T;T
Sift4G
Benign
0.55
T;T
Polyphen
0.82
P;.
Vest4
0.29
MVP
0.84
MPC
1.0
ClinPred
0.031
T
GERP RS
4.7
Varity_R
0.12
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs781687346; hg19: chr1-160085659; COSMIC: COSV63404257; API